NCT04039061Recruiting
ADPKD Patient Registry
Autosomal Dominant Polycystic Kidney Disease Patient Registry
Source: ClinicalTrials.gov · Last updated 22 Sept 2026
Brief summary (registry, in English)
The purpose of the ADPKD Registry is to create an online patient network that includes at least 5,000 people with Autosomal Dominant Polycystic Kidney Disease (ADPKD) who contribute data on their health and other topics. The ADPKD Patient Registry aims to support important scientific discoveries and support patient needs in the following ways: * Connect ADPKD patients with opportunities to join clinical studies. * Collect data for the research community to better describe the ADPKD disease experience and improve patient care. * Engage with patients by measuring quality of life outcomes.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 3000 (estimated)
- First submitted
- 29 Jul 2019
- Start date
- Sept 2019
- Primary completion date
- Sept 2029
- Lead sponsor
- PKD Foundation
- Diseases
- Polycystic kidney disease
- NCT number
- NCT04039061
What you commit to
- Study type: Observational
- Planned participants: 3000
- From Sept 2019 to the primary completion date, Sept 2029
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- caretakers, family members or friends of individuals with ADPKD
Who the study is looking for
- Diagnosis or suspected diagnosis with autosomal dominant polycystic kidney disease (ADPKD)
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| PKD Foundation Coordinator of this site? Confirm its status | Kansas City | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.